Havana, December 6 (RHC)-- The population of four municipalities in Cuba's capital will receive an anti-Covid-19 booster dose starting Monday, in the continuation of the process initiated with health workers.

The territories selected to administer the nationally produced immunogen Abdala are Guanabacoa, Regla, La Habana del Este, and San Miguel del Padrón, said the province's deputy director-general of the health Nilda Roca.

In a recent session of the city's working group for the confrontation of the SARS-CoV-2 coronavirus, the doctor explained that those who are not convalescing from the disease and who have been inoculated for six months with the complete scheme of any vaccine would be included.

The first stage also included Biocubafarma personnel and other at-risk groups throughout the Caribbean island. To date, the reinforcement has reached 360,000  Cubans, according to the latest update from the Ministry of Public Health (MINSAP).

Miladys Limonta, the coordinator of projects for developing anti-Covid-19 vaccine candidates at the Center for Genetic Engineering and Biotechnology, highlighted days ago the suitability of Abdala to stimulate the immune response as a booster.

The drug - the first to be created and manufactured in Latin America and the Caribbean - demonstrated this capacity in convalescent individuals, subjects previously injected with other formulations, such as Sputnik and Sinopharm, said the scientist.

Likewise, in those vaccinated five months earlier with the complete scheme of Soberana 02 plus Soberana Plus, as well as with Abdala itself, Limonta argued.

There is evidence that protection against resistant strains of the coronavirus is greater as the antibody titer increases, and the booster doses guarantee the selection of memory clones and a longer duration of the immune response, Limonta concluded.